4-bromo-3-fluoropyridine

We are 4-bromo-3-fluoropyridine CAS:2546-52-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-bromo-3-fluoropyridine
CAS.NO: 2546-52-3
Synonyms: 4-bromo-3-fluoro-pyridine;
3-Fluoro-4-bromopyridinehydrochloride;
3-Fluor-4-brom-pyridin;
Pyridine,4-bromo-3-fluoro;
bromo-4 fluoro-3 pyridine;
Molecular Formula: C5H4BrClFN
Molecular Weight: 212.44700
 
Physical and Chemical Properties:
Density: 1.707g/cm3
Melting point: /
Boiling point: 169.2ºC at 760mmHg
Flash point: 56.1ºC
Index of Refraction: 1.533
 
Specification:
Appearance: Light yellow liquid
Purity:≥98.0%
 
Packing:25 KGS/Drum
Storage:Store in a tightly closed container. Store in a cool, dry
Application:   used in the Pharmaceutical intermediate

4-bromo-3-fluoropyridine


Related News: In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.70321-86-7 Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.372-30-5 Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.1-Bromo-4-nitrobenzene CAS:586-78-7 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.

Related Products
Product Name
H-VAL-TYR-OH View Details
Myristoyl Pentapeptide-8 View Details
2-Acetyl-1-ethylpyrrole View Details
Ethyl 5-oxo-1-phenyl-2-pyrazoline-3-carboxylate manufacturer 2,4-Diethyl-9H-Thioxanthen-9-One manufacturer 3-methoxyphenol manufacturer 2′,4′-Dichlorovalerophenone manufacturer 2-chloro-4-(piperidin-1-ylmethyl)pyridine,oxalic acid manufacturer